Kleem Chaudhary, PhD

Venture Partner

Dr. Chaudhary is a Venture Partner at Raven. He has held roles of increasing responsibility across biotech and pharma, including President and CEO of Hyku Biosciences, a non-cysteine covalent precision medicine company. Prior to Hyku, he was Chief Operating and Business Officer at Redona Therapeutics, a company targeting dysregulated RNA and DNA processes in serious diseases.Prior to Redona, he was Chief Business Officer at Checkmate Pharmaceuticals, an immuno-oncology company, where he was instrumental in its Series C financing and IPO and led the subsequent sale of the company to Regeneron. Earlier in his career, he held business development roles of increasing responsibility at Novartis, Takeda, and Biogen. Dr. Chaudhary started his industry career as a medicinal chemist at Gilead Sciences. He holds a PhD in Chemistry from the University of North Carolina at Chapel Hill and a BSc in Chemistry from the University of Winnipeg.